Participate in Cannabis Peer Review Study and Help Prove Marijuana is Medicine
Posted by Marijuana Doctors on 10/05/2016 in Research and Studies
Updated on February 1, 2019. Medical content reviewed by Dr. Joseph Rosado, MD, M.B.A, Chief Medical Officer
If you are a state-qualified medical marijuana patient, you are invited to participate in a crowd-sourced cannabis peer-review study in efforts to help prove that marijuana is medicine.
The purpose of this crowd-sourced cannabis peer review study, is to collect the pertinent data necessary to help prove that marijuana is medicine. On August 11, 2016, the Drug Enforcement Agency announced it has again denied two petitions to reschedule marijuana under the Controlled Substances Act (CSA), citing that marijuana remains a schedule 1 controlled substance — along with the likes of Heroin (diacetylmorphine), LSD (Lysergic acid diethylamide), MDMA (3,4-methylenedioxymethamphetamine or “ecstasy”), GHB (gamma-hydroxybutyric acid), Methaqualone (Quaalude), Khat (Cathinone), and Bath Salts (3,4-methylenedioxypyrovalerone or MDPV) — because, “it does not meet the criteria for currently accepted medical use in treatment in the United States, there is a lack of accepted safety for its use under medical supervision, and it has a high potential for abuse.”
To participate in the nationwide crowd-sourced cannabis peer review study, simply register or log in on MarijuanaDoctors.com via a computer, tablet or smartphone, or download the MarijuanaDoctors.com mobile app for free to start using the medical marijuana “Symptom Tracker”. However, for patient’s ease and convenience the tracker is just as easily accessed by logging in on the company’s mobile site and website online, as well.
The tracker is designed to capture the titration data relevant to each patient’s medical ailment and condition, while also giving patients the ability to track and monitor their own personal progress. This insight will allow patients to speak to their marijuana doctor about ways in which the patient’s condition may be further improved. Furthermore the patient’s physician will develop a greater understanding of how to better care for other patients, with similar symptoms and ailments.
The symptom tracker will document the data of the patient’s traditional treatment including the patient’s ailment, and the list of traditional medications that the patient is also using to treat their condition. The alternative treatment section will document the specific cannabis strain that the patient is medicating with, as well as the patient’s chosen dosage level in grams. Patients will then be asked to specify their chosen method of consumption, selecting either flower, oil, wax, edibles or tinctures; and their chosen device for medicating, specifying either paper, pipe, water pipe or vaporizer.
The patient will then input information specific to the effectiveness of the medical marijuana treatment by specifying the symptom; the severity of the symptom before treatment, on a scale of 1-10; and the severity of the symptom after treatment, on a scale of 1-10.
The documented data will define which cannabis strains are most effective at treating which ailments, conditions and symptoms.
The tracker’s results are graphically sorted according to states and individual condition symptoms, and the BETA launch of the mobile app has already produced crowd-sourced results under the ailments of anxiety disorders; chronic pain; seizures; severe nausea; sleep apnea.
Making it’s debut in the October 2016 Symptom Tracker Monthly Newsletter, the cannabis peer review study and tracker’s findings, will be the featured in the company’s monthly newsletter keeping readers informed on the study’s developments, accompanied by easy-to-understand graphs.
The Symptom Tracker’s primary objective is to bridge the understanding between marijuana doctors, patients and their diagnosed ailments/conditions, ultimately allowing the patient to enjoy a greater quality of life. Furthermore, in states like New York where the medical marijuana program is medically restrictive, the tracker serves as a platform for qualified patients to aid in expanding their state’s access to a greater number of debilitating conditions — there are currently more than 13,478 patients waiting for the New York Medical Marijuana Program to allow patients diagnosed with debilitating conditions like chronic pain and Post Traumatic Stress Disorder (PTSD), entry and access to compassionate care.
Register now to join the first crowd-sourced cannabis peer-review study for the sake of patients worldwide, and manage your medical marijuana needs mobily to help document the data that will prove, marijuana is medicine.